BIONTECH SE ($BNTX) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of -$1.95 per share, beating estimates of -$2.27 by $0.32. The company also reported revenue of $118,174,820, missing estimates of $170,332,962 by $-52,158,142.
You can see Quiver Quantitative's $BNTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIONTECH SE Insider Trading Activity
BIONTECH SE insiders have traded $BNTX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BNTX stock by insiders over the last 6 months:
- SIERK POETTING (Chief Operating Officer) sold 50,000 shares for an estimated $5,527,960
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
BIONTECH SE Hedge Fund Activity
We have seen 135 institutional investors add shares of BIONTECH SE stock to their portfolio, and 121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 6,634,492 shares (-84.2%) from their portfolio in Q4 2025, for an estimated $631,603,638
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,746,944 shares (-36.1%) from their portfolio in Q4 2025, for an estimated $166,309,068
- PFIZER INC removed 1,658,361 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $157,875,967
- JANE STREET GROUP, LLC added 1,164,203 shares (+590.9%) to their portfolio in Q4 2025, for an estimated $110,832,125
- FLOSSBACH VON STORCH SE removed 515,733 shares (-12.3%) from their portfolio in Q1 2026, for an estimated $45,038,962
- D. E. SHAW & CO., INC. added 488,552 shares (+inf%) to their portfolio in Q4 2025, for an estimated $46,510,150
- FMR LLC added 480,114 shares (+8.8%) to their portfolio in Q4 2025, for an estimated $45,706,852
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
BIONTECH SE Analyst Ratings
Wall Street analysts have issued reports on $BNTX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/10/2025
To track analyst ratings and price targets for BIONTECH SE, check out Quiver Quantitative's $BNTX forecast page.
BIONTECH SE Price Targets
Multiple analysts have issued price targets for $BNTX recently. We have seen 8 analysts offer price targets for $BNTX in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $130.0 on 04/27/2026
- Terence Flynn from Morgan Stanley set a target price of $126.0 on 04/10/2026
- Etzer Darout from BMO Capital set a target price of $128.0 on 03/11/2026
- Geoff Meacham from Citigroup set a target price of $130.0 on 03/11/2026
- Yaron Werber from TD Cowen set a target price of $94.0 on 03/11/2026
- John Newman from Canaccord Genuity set a target price of $171.0 on 03/11/2026
- Akash Tewari from Jefferies set a target price of $138.0 on 03/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
